Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences

Behavioural Brain Research

Volumn 286, Issue , 2015, Pages 49-56

  Marinho, A L Z ^a   Vila Verde, C ^a   Fogaca M V ^a   Guimaraes F S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

5HT1A receptors; Anxiety; Cannabidiol; Infralimbic; Prefrontal cortex; Stress

Indexed keywords

CANNABIDIOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PSYCHOTROPIC AGENT; PYRIDINE DERIVATIVE; SEROTONIN 1 ANTAGONIST;

ACUTE STRESS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONCENTRATION RESPONSE; CONDITIONED EMOTIONAL RESPONSE TEST; CONDITIONING; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; EMOTIONAL STRESS; EXPERIMENTAL ANXIETY TEST; FEAR; FOOTSHOCK; IMMOBILIZATION STRESS; LIMBIC CORTEX; MALE; MICROINJECTION; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; DRUG THERAPY; ELECTRIC SHOCK; EXERCISE; EXPLORATORY BEHAVIOR; FOOT; MENTAL STRESS; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX; WISTAR RAT;

ANIMALS; ANXIETY; CANNABIDIOL; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EXPLORATORY BEHAVIOR; FEAR; FOOT; MALE; MICROINJECTIONS; PIPERAZINES; PREFRONTAL CORTEX; PSYCHOTROPIC DRUGS; PYRIDINES; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RESTRAINT, PHYSICAL; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; STRESS, PSYCHOLOGICAL;

EID: 84924732264     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.02.023     Document Type: Article

References (89)

1. Dalley J.W., Cardinal R.N., Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 2004, 28:771-784.
2. Dias R., Robbins T.W., Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 2006, 380:69-72.
3. Bussey T.J., Everitt B.J., Robbins T.W. Dissociable effects of cingulated and medial frontal lesions on stimulus-reward learning using a novel Pavlovian autoshaping procedure for the rat: implications for the neurobiology of emotion. Behav Neurosci 1997, 111:908-919.
4. Ongur D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000, 10:206-219.
5. Berendse H.W., Groenewegen H.J. Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat. Neuroscience 1991, 42:73-102.
6. Ray J.P., Price J.L. The organization of the thalamocortical connections of the mediodorsal thalamic nucleus in the rat, related to the ventral forebrain prefrontal cortex topography. J Comp Neurol 1992, 323:167-197.
7. Heidbreder C.A., Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 2003, 27:555-579.
8. Tavares R.F., Correa F.M., Resstel L.B. Opposite role of infralimbic and prelimbic cortex in the tachycardiac response evoked by acute restraint stress in rats. J Neurosci Res 2009, 87(11):2601-2607.
9. Lemos J.I., Resstel L.B., Guimarães F.S. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav Brain Res 2010, 207:105-111.
10. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn Mem 2006, 13:728-733.
11. Lisboa S.F., Stecchini M.F., Correa F.M., Guimaraes F.S., Resstel L.B. Different role of the ventral medial prefrontal cortex on modulation of innate and associative learned fear. Neuroscience 2010, 171:760-768.
12. Bergamaschi M.M., Queiroz R.H., Zuardi A.W., Crippa J.A. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 2011, 6:237-249.
13. Campos A.C., Moreira F.A., Gomes F.V., Del Bel E.A., Guimarães F.S. Multiples mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B: Biol Sci 2012, 367:3364-3378.
14. Guimarães F.S., Chiaretti T.M., Graeff F.G., Zuardi A.W. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 1990, 100:558-559.
15. Zuardi A.W., Cosme R.A., Graeff F.G., Guimarães F.S. Effects of ipsapirone and cannabidiol on human experimental anxiety. J Psychopharmacol 1993, 7(1):82-88.
16. 1A receptors. Br J Pharmacol 2010, 159:122-128.
17. Moreira F.A., Aguiar D.C., Guimarães F.S. Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1466-1471.
18. Resstel L.B., Joca S.R., Moreira F.A., Correa F.M., Guimarães F.S. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res 2006, 172:294-298.
19. 1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berlin) 2008, 199:223-230.
20. 1A receptors. Psychopharmacology (Berlin) 2011, 213:465-473.
21. Gomes F.V., Reis D.G., Alves F.H., Corrêa F.M., Guimarães F.S., Resstel L.B. Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J Psychopharmacol 2012, 26:104-113.
22. Fogaça M.V., Reis F.M.C.V., Campos A.C., Guimarães F.S. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Eur Neuropharmacol 2013, 24(3):410-419.
23. Inoue T., Tsuchiya K., Koyama T. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Pharmacol Biochem Behav 1996, 53:825-831.
24. File S.E., Mabbutt P.S., Hitchcott P.K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berlin) 1990, 102:98-101.
25. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press, Amsterdam.
26. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 2003, 70:83-244.
27. Izzo A.A., Borreli F., Capasso R., Di Marzo V., Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 2009, 30:515-552.
28. Petitet F., Jeantaud B., Reibaud M., Imperato A., Dubroeucq M.C. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci 1998, 63:1-6.
29. Thomas A., Burant A., Bui N., Graham D., Yuva-Paylor L.A., Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berlin) 2009, 204:361-373.
30. Bisogno T., Hanus L., De Petrocellis L., Tchilibon S., Ponde D.E., Brandi I. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Braz J Pharmacol 2001, 134:845-852.
31. Russo E.B., Burnett A., Hall B., Parker K.K. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 2005, 30:1037-1043.
32. Russo E.B. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol 2011, 163:1344-1364.
33. Carrier E.J., Auchampach J.A., Hillard C.J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci U S A 2006, 103:7895-7900.
34. Campos A.C., Guimarães F.S. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuro-Psychopharmacol Biol Psychiatry 2009, 33(8):1517-1521.
35. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J Comp Physiol Psychol 1972, 81:281-290.
36. Smith Y., Paré D. Intra-amygdaloid projections of the lateral nucleus in the cat: PHA-L anterograde labeling combined with postembedding GABA and glutamate immunocytochemistry. J Comp Neurol 1994, 342:232-248.
37. Paré D., Smith Y., Paré J.F. Intra-amygdaloid projections of the basolateral and basomedial nuclei in the cat: Phaseolus vulgaris-leucoagglutinin anterograde tracing at the light and electron microscopic level. Neuroscience 1995, 69:567-583.
38. Pitkanen A., Stefanacci L., Farb C.R., Go G.G., LeDoux J.E., Amaral D.G. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. J Comp Neurol 1995, 356:288-310.
39. Holstege G., Bandler R., Saper C.B. The emotional motor system. Prog Brain Res 1996, 107:3-6.
40. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1998, 8:2517-2529.
41. De Oca B.M., DeCola J.P., Maren S., Fanselow M.S. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 1998, 18(9):3426-3432.
42. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol Psychiatry 2001, 6:13-34.
43. Corcoran K.A., Quirk G.J. Activity in prelimbic cortex is necessary for the expression of learned, but not innate, fears. J Neurosci 2007, 24:840-844.
44. Quirk G.J., Likhtik E., Pelletier J.G., Pare D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 2003, 23:8800-8807.
45. Milad M.R., Vidal-Gonzalez I., Quirk G. Electrical stimulation of medial prefrontal cortex reduces conditioned fear in a temporally specific manner. Behav Neurosci 2004, 118:389-394.
46. Barners N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
47. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., Ehrlich I., Sprengel R., Deisseroth K., Stadler M.B., Müller C., Lüthi A. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468:277-282.
48. Ji G., Neugebauer V. Modulation of medial prefrontal cortical activity using in vivo recordings and optogenetics. Mol Brain 2012, 5:2-10.
49. Blum S., Hebert A.E., Dash P.K. A role for the prefrontal cortex in recall of recent and remote memories. Neuroreport 2006, 17:341-344.
50. Laurent V., Westrook R.F. Inactivation of the infralimbic but not the prelimbic cortex impairs consolidation and retrieval of fear extinction. Learn Mem 2009, 16:520-529.
51. Pratt J.A. The neuroanatomical basis of anxiety. Pharmacol Ther 1992, 55:149-181.
52. Ishida Y., Hashiguchi H., Takeda R., Ishizuka Y., Mitsuyama Y., Kannan H., Nishimori T., Nakahara D. Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse 2002, 45:46-51.
53. Sesack S.R., Deutc A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 1989, 290:213-242.
54. Hurley K.M., Herbert H., Moga M.M., Saper C.B. Efferent projections of the infralimbic cortex of the rat. J Comp Neurol 1991, 308:249-276.
55. Takagishi M., Chiba T. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res 1991, 566:26-39.
56. Groenewegen H.J., Uylings H.B.M. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res 2000, 126:3-28.
57. Hajós M., Richards C.D., Székely A.D., Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 1998, 87:95-108.
58. 2+ influx in rat basolateral amygdala via 5-HT1A receptors. Eur J Neurosci 1998, 10:2163-2172.
59. Lin C.H., Huang Y.C., Tsai J.J., Gean P.W. Modulation of voltage-dependent calcium currents by serotonin in acutely isolated rat amygdala neurons. Synapse 2001, 41:351-359.
60. Wang S.J., Coutinho V., Sivra T.S. Presynaptic cross-talk of adrenoceptor and 5-hydroxytryptamine receptor signalling in the modulation of glutamate release from cerebrocortical nerve terminals. Br J Pharmacol 2002, 137:1371-1379.
61. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., Tecott L.H. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Aca Sci U S A 1998, 95:15049-15054.
62. Sibille E., Hen R. Serotonin1A receptors in mood disorders: a combined genetic and genomic approach. Behav Pharmacol 2001, 12:429-438.
63. Pattij T., Groenink L., Hijzen T.H., Oosting R.S., Maes R.A.A., Van Der Gugten J., Olivier B. Autonomic changes associated with enhanced anxiety in 5-HT1A receptor knock-out mice. Neuropsychopharmacology 2002, 27:380-390.
64. Groenink L., Pattij T.D., Jongh R., Van Der Gugten J., Oosting R.S., Dirks A., Olivier B. 5-HT1A receptor knock-out mice and mice overexpressing corticotrophin-releasing hormone in models of anxiety. Eur J Pharmacol 2003, 463:185-197.
65. Toth M. 5-HT1A receptor knock-out mouse as a genetic model of anxiety. Eur J Pharmacol 2003, 463:177-184.
66. 2+/calmodulin-dependent kinase II in prefrontal cortical pyramidal neurons. J Biol Chem 2002, 277:36553-36562.
67. Bi L.L., Wang J., Luo Z.Y., Chen S.P., Geng F., Chen Y.H., Li S.J., Yuan C.H., Lin S., Gao T.M. Enhanced excitability in the infralimbic cortex produces anxiety-like behaviors. Neuropharmacology 2013, 72:148-156.
68. Krieger J.E., Graeff F.G. Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Braz J Med Biol Res 1985, 18:61-67.
69. Bandler R., Carrive P. Integrated defence reaction elicited by excitatory amino acid microinjection in the midbrain periaqueductal gray region of the unrestrained cat. Brain Res 1998, 439:95-106.
70. Gerhardt C.C., Heerikhuizen H. Functional characteristics of heterologously expressed 5-HT receptors. Eur J Pharmacol 1997, 334:1-23.
71. Guimarães F.S., Carobrez A.P., De Aguiar J.C., Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal gray. Psychopharmacology (Berlin) 1991, 103:91-94.
72. Molchanov M.L., Guimarães F.S. Defense reaction induced by a metabotropic glutamate receptor agonist microinjected into the dorsal periaqueductal gray of rats. Braz J Med Biol Res 1999, 32:1533-1537.
73. Matheus M.G., Guimarães F.S. Antagonism of non-NMDA receptors in the dorsal periaqueductal gray induces anxiolytic effect in the elevated plus maze. Psychopharmacology (Berlin) 1997, 132:14-18.
74. Russo A.S., Guimarães F.S., De Aguiar J.C., Graeff F.G. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Psychopharmacology (Berlin) 1993, 110:198-202.
75. Russo A.S., Guimarães F.S., De Aguiar J.C., Graeff F.G. Anxiolytic effect of midazolam microinjected into the dorsal periaqueductal grey area of rats. Braz J Med Biol Res 1991, 24:607-609.
76. Campos A.C., Fogaça M.V., Aguiar D.C., Guimaraes F.S. Animal models of anxiety disorders and stress. Rev Bras Psiquiatr 2013, 35:101-111.
77. Raymond J.R., Mukhin Y.V., Gettys T.W., Garnovsakaya M.N. The recombinant 5-HT1A receptor: G-protein coupling and signaling pathways. Brit J Pharmacol 1999, 127:1751-1764.
78. Rodgers R.J., Cole J.C., Aboualfa K., Stephenson L.H. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol Biochem Behav 1995, 52:805-813.
79. Reis F.M., Albrechet-Souza L., Franci C.R., Brandão M.L. Risk assessment behaviors associated with corticosterone trigger the defense reaction to social isolation in rats: role of the anterior cingulate cortex. Stress 2012, 15:318-328.
80. Maier S.F., Watkins L.R. Role of the medial prefrontal cortex in coping and resilience. Brain Res 2010, 1355:52-60.
81. Maier S.F., Watkins L.R. Stressor controllability, anxiety, and serotonin. Cogn Therapy Res 1998, 6:595-613.
82. Resstel L.B., Souza R.F., Guimarães F.S. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test. Physiol Behav 2008, 93:200-205.
83. Padovan C.M., Guimarães F.S. Restraint-induced hypoactivity in an elevated plus-maze. Braz J Med Res 2000, 33:79-83.
84. Campos A.C., Ferreira F.R., Guimarães F.S., Lemos J.I. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience 2010, 167:238-246.
85. Albonetti M.E., Farabollini F. Behavioural responses to single and repeated restraint in male and female rats. Behav Process 1992, 28:97-110.
86. Mendonça F.H., Félix F.H., Del-Bel E.A., Guimarães F.S. Intraventricular cycloheximide attenuates the restraint-induced long-lasting effect on plus maze exploration. Braz J Med Biol Res 1996, 29:501-505.
87. De Paula Soares V., Vicente M.A., Biojone C., Zangrossi H.J.R., Guimarães F.S., Joca S.R. Distinct behavioral consequences of stress models of depression in the elevated T-maze. Behav Brain Res 2011, 225:590-595.
88. Radley J.J., Arias C.M., Sawchenko P.E. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. J Neurosci 2006, 26:12967-12976.
89. Izquierdo A., Wellman C.L., Holmes A. Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci 2006, 23:4406-4409.